- Home
- CCII vs SENS Comparison
CCII vs SENS Comparison
Compare CCII & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$8.37
Company Overview
Basic Information| Metric | CCII | SENS |
|---|---|---|
| Founded | 2024 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 355.3M | 308.5M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | CCII | SENS |
|---|---|---|
| Price | $10.26 | $8.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $25.58 |
| AVG Volume (30 Days) | 92.9K | ★ 485.7K |
| Earning Date | 01-01-0001 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | N/A | $59.55 |
| Revenue Next Year | N/A | $69.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $10.07 | $0.41 |
| 52 Week High | $10.47 | $8.75 |
Technical Indicators
Market Signals| Indicator | CCII | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 48.47 | 64.25 |
| Support Level | $10.18 | $7.35 |
| Resistance Level | $10.30 | $8.74 |
| Average True Range (ATR) | 0.02 | 0.53 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 46.67 | 80.20 |
Price Performance
Historical Comparison CCII
SENS
About CCII Cohen Circle Acquisition Corp. II Class A Ordinary Shares
Cohen Circle Acquisition Corp II is a blank check company.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.